T

Bio-Techne Corp
D

TECH

71.070
USD
2.39
(3.48%)
Market Closed
Volume
0
EPS
2
Div Yield
0.45
P/E
68
Market Cap
11,274,935,401
OverviewSignalsIdeasNews
Related Instruments
    AAPL
    AAPL
    -3.130
    (-1.37%)
    228.5 USD
    AMZN
    AMZN
    -8.930
    (-4.22%)
    198.3 USD
    GOOGL
    GOOGL
    -3.110
    (-1.77%)
    167.64 USD
    IBM
    IBM
    -4.040
    (-1.93%)
    222.41 USD
    INTC
    INTC
    -0.695
    (-2.78%)
    24.45 USD
    MSFT
    MSFT
    -11.75
    (-2.75%)
    412.83 USD
    NVDA
    NVDA
    -4.900
    (-3.34%)
    146.66 USD
    ORCL
    ORCL
    -3.380
    (-1.81%)
    192.42 USD
    TSLA
    TSLA
    9.69
    (3.11%)
    339.6 USD
    More
News

Title: Bio/Techne Corp

Sector: Healthcare
Industry: Biotechnology
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of theworld accounting for the remaining 5%.